JackDavidSchimMDFAHS

Neurology • Carlsbad, CA

Headache

Chair of the Division of Neuroscience at Scripps Hospital. Medical Director of the Stroke Program at Tri-City Medical Center.

Join to view full profile

Dr. Schim is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Schim's full profile

Already have an account?

Office
6010 Hidden Valley Rd
Ste 200
Carlsbad, CA 92011
Phone+1 760-631-3000

Fax+1 760-631-3016

Education & Training

University of California (San Diego) Medical CenterResidency, Neurology, 1982 - 1985
Cedars-Sinai Medical CenterInternship, Internal Medicine, 1981 - 1982
University of California San Diego School of MedicineClass of 1981

Certifications & Licensure

CA State Medical License 1982 - 2025
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
Top MD Consumers Checkbook

Publications & Presentations

PubMed

129 citations
Expert consensus recommendations for the performance of peripheral nerve blocks for headaches--a narrative review.
Andrew M. Blumenfeld, Avi Ashkenazi, Uri Napchan, Steven D. Bender, Brad C. Klein
Headache. 2013-03-01
30 citations
Efficacy and safety of lasmiditan in patients using concomitant migraine preventive medications: findings from SAMURAI and SPARTAN, two randomized phase 3 trials.
Li Shen Loo, Jessica Ailani, Jack Schim, Simin K. Baygani, Hans-Peter Hundemer
The Journal of Headache and Pain. 2019-07-24
48 citations
Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review.
Andrew M. Blumenfeld, Benjamin M. Frishberg, Jack Schim, Ashley Iannone, Gary Schneider
Pain and Therapy. 2021-04-21

Press Mentions

Upsher-Smith Reimagines Prescriber Education with Launch of Migraine PeerConnectDecember 8th, 2020
Alder BioPharmaceuticals® to Present New Analyses of Eptinezumab’s Clinical Trial Data Describing Early, Robust Migraine Prevention and Quality of Life Impact at 2019 American Academy of Neurology Annual MeetingApril 23rd, 2019
Pure Tension-Type Headache Versus Tension-Type Headache in the MigraineurSeptember 28th, 2010